Euro Non-Callable Healthcare & Pharmaceuticals Corporate Bond Yields (EUR)
Fitted spot curve as of 2026-09-11
https://bondscovery.com/yield-curve/eur-corporate-healthcare-pharmaceuticals-non-callable
Euro Non-Callable Healthcare & Pharmaceuticals Corporate Bond Yields (EUR) as of 2026-09-11: 10Y at 4.30%, fitted curve 1M–30Y (3.16%–5.09%), 84 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 3.16% | — |
| 3M | 3.19% | 3.20% |
| 6M | 3.23% | 3.32% |
| 12M | 3.32% | 3.44% |
| 18M | 3.41% | 3.64% |
| 2Y | 3.50% | 3.81% |
| 3Y | 3.65% | 4.01% |
| 4Y | 3.77% | 4.22% |
| 5Y | 3.88% | 4.42% |
| 6Y | 3.99% | 4.62% |
| 7Y | 4.08% | 4.79% |
| 8Y | 4.17% | 4.93% |
| 9Y | 4.24% | 5.03% |
| 10Y | 4.30% | 5.08% |
| 15Y | 4.50% | 5.14% |
| 20Y | 4.75% | 6.14% |
| 25Y | 4.99% | 7.16% |
| 30Y | 5.09% | 6.41% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 3.50% and the 10-year 4.30%, a 10Y−2Y spread of +80 bp — positively sloped — as of 2026-09-11. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-11 | 1m ago2026-08-12 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-14 | 5m ago2026-04-14 | 6m ago2026-03-16 |
|---|---|---|---|---|---|---|---|
| 2Y | 3.50% | 3.06% | 3.04% | 3.05% | 3.06% | 3.02% | 2.75% |
| 10Y | 4.30% | 3.94% | 3.90% | 3.83% | 3.90% | 3.84% | 3.75% |
| 10Y − 2Y | +80 bp | +87 bp | +86 bp | +78 bp | +84 bp | +82 bp | +101 bp |
Yields by rating group
The same curve split by credit quality: 76 rated bonds across 3 rating bands, all maturities pooled. Median yield by band: AAA to AA- 3.58%, A+ to BBB- 4.11%, Speculative 5.76%.
Bonds in this curve
A selection of 30 of the 84 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Abbott Laboratories | 3.26% | 2026-09-27 | 1.50% | XS1883355197 |
| Fresenius SE & CO Kgaa | 3.14% | 2026-11-30 | 0.62% | XS2084497705 |
| Sanofi SA | 3.31% | 2027-01-13 | 0.50% | FR0013201639 |
| Astrazeneca PLC | 3.19% | 2027-03-03 | 3.62% | XS2593105393 |
| Medtronic Global Holdings SCA | 3.27% | 2027-03-07 | 1.12% | XS1960678255 |
| Novartis | 2.98% | 2027-09-30 | 1.12% | XS1585010074 |
| Abbott Laboratories | 3.27% | 2027-11-19 | 0.38% | XS2076155105 |
| Sanofi SA | 3.37% | 2028-04-05 | 1.12% | FR0013144003 |
| Astrazeneca PLC | 3.25% | 2028-05-12 | 1.25% | XS1411404426 |
| Medtronic Global Holdings SCA | 3.50% | 2028-10-15 | 3.00% | XS2535308477 |
| Stryker Corp | 3.67% | 2028-12-11 | 3.38% | XS2732952838 |
| Sanofi SA | 3.44% | 2029-03-21 | 0.88% | FR0013409844 |
| Sanofi SA | 3.45% | 2029-04-06 | 1.25% | FR0014009KQ0 |
| Novonesis A/S | 3.75% | 2030-03-19 | 3.25% | XS3320129599 |
| Sanofi SA | 3.50% | 2030-03-21 | 1.38% | FR0013324357 |
| Galderma Finance Europe BV | 4.26% | 2031-03-17 | 3.38% | XS3310319689 |
| Sartorius Finance BV | 4.13% | 2031-05-12 | 3.75% | XS3352063047 |
| Ipsen SA | 4.37% | 2032-03-25 | 3.88% | FR001400YD27 |
| Sanofi SA | 3.88% | 2032-06-23 | 3.00% | FR0014010MR2 |
| Novonesis A/S | 4.08% | 2033-03-19 | 3.62% | XS3320130175 |
| Becton Dickinson & CO | 4.28% | 2033-05-20 | 3.85% | XS3368849348 |
| Sanofi SA | 3.89% | 2034-03-21 | 1.25% | FR0013409851 |
| Danaher Corporation | 4.09% | 2034-04-29 | 3.62% | XS3352083409 |
| Sandoz Finance B.V. | 4.36% | 2035-03-26 | 4.00% | XS3032013511 |
| Astrazeneca PLC | 4.25% | 2035-09-01 | 3.92% | XS3484302545 |
| GSK Capital BV | 4.26% | 2036-11-19 | 3.25% | XS2933692753 |
| Medtronic Global Holdings SCA | 4.51% | 2039-07-02 | 1.50% | XS2020670936 |
| Roche Holding AG | 4.40% | 2044-05-03 | 3.56% | XS2813211617 |
| Medtronic Global Holdings SCA | 5.03% | 2049-07-02 | 1.75% | XS2020671157 |
| BMS Ireland Capital Funding DAC | 5.17% | 2055-11-10 | 4.58% | XS3215466767 |